COVID 19: Diabetes and Obesity API-ICP Recommendations.

Betacoronavirus Blood Glucose / analysis COVID-19 Coronavirus Infections / complications Diabetes Mellitus, Type 2 / complications Humans Hypoglycemic Agents / therapeutic use Insulin / therapeutic use Obesity / complications Pandemics Pneumonia, Viral / complications Risk Factors SARS-CoV-2

Journal

The Journal of the Association of Physicians of India
ISSN: 0004-5772
Titre abrégé: J Assoc Physicians India
Pays: India
ID NLM: 7505585

Informations de publication

Date de publication:
May 2020
Historique:
entrez: 3 7 2020
pubmed: 3 7 2020
medline: 8 7 2020
Statut: ppublish

Résumé

Diabetes and Obesity are major risk factors which confer vulnerability to Covid 19 . Diabetes has immune defects which makes the individual susceptible to infections and covid 19 is no exception . Also covid 19 can cause pancreatic damage as well as stress hyperglycaemia in hospitals which may need Insulin . Among diabetes male gender,elderly,hypertension ,heart disease and chronic renal disease are more vulbwdvale to covid 19 and need strict supervision . Diabetes management in hospitalised situation merits early diabetes specific nutrition with Insulin. Adherence to lifestyle with self monitoring of blood glucose and adequate supply of Insulin and Oral antidiabetic agents is encouraged.

Identifiants

PMID: 32610865
pubmed: 32610865

Substances chimiques

Blood Glucose 0
Hypoglycemic Agents 0
Insulin 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

42-44

Informations de copyright

© Journal of the Association of Physicians of India 2011.

Auteurs

Shashank R Joshi (SR)

Dean, Indian College of Physicians; Consultant Endocrinologist, Lilawati Hospital, Bhatia Hospital, Apollo Sugar Clinic, Mumbai, Maharashtra.

Mangesh H Tiwaskar (MH)

Asian Heart instituite, Mumbai, Maharashtra.

Siddharth N Shah (SN)

Consultant at Bhatia Hospital, Mumbai, Maharashtra.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Virus › Virus à ARN › Virus à ARN à brin positif › Nidovirales › Coronaviridae › Coronavirus › Betacoronavirus › COVID 19: Diabetes and Obesity API-ICP Recommendations.
questionsmedicales.fr › Glucides › Sucres › Oses › Hexose › Glucose › Glycémie › COVID 19: Diabetes and Obesity API-ICP Recommendations.
questionsmedicales.fr › Maladies de l'appareil respiratoire › Infections de l'appareil respiratoire › Pneumopathie infectieuse › Pneumopathie virale › COVID-19 › COVID 19: Diabetes and Obesity API-ICP Recommendations.
questionsmedicales.fr › Infection › Maladies virales › Infections à virus à ARN › Infections à Nidovirales › Infections à Coronaviridae › Infections à coronavirus › COVID 19: Diabetes and Obesity API-ICP Recommendations.
questionsmedicales.fr › Maladies endocriniennes › Diabète › Diabète de type 2 › COVID 19: Diabetes and Obesity API-ICP Recommendations.
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › COVID 19: Diabetes and Obesity API-ICP Recommendations.
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Effets physiologiques des médicaments › Hypoglycémiants › COVID 19: Diabetes and Obesity API-ICP Recommendations.
questionsmedicales.fr › Acides aminés, peptides et protéines › Peptides › Hormones peptidiques › Hormones pancréatiques › Insulines › Insuline › COVID 19: Diabetes and Obesity API-ICP Recommendations.
questionsmedicales.fr › États, signes et symptômes pathologiques › Signes et symptômes › Obésité › COVID 19: Diabetes and Obesity API-ICP Recommendations.
questionsmedicales.fr › Environnement et santé publique › Santé publique › Épidémies de maladies › Épidémies › Pandémies › COVID 19: Diabetes and Obesity API-ICP Recommendations.
questionsmedicales.fr › Maladies de l'appareil respiratoire › Infections de l'appareil respiratoire › Pneumopathie infectieuse › Pneumopathie virale › COVID 19: Diabetes and Obesity API-ICP Recommendations.
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Probabilité › Risque › Facteurs de risque › COVID 19: Diabetes and Obesity API-ICP Recommendations.
questionsmedicales.fr › Virus › Virus à ARN › Virus à ARN à brin positif › Nidovirales › Coronaviridae › Coronavirus › Betacoronavirus › Virus du SRAS › SARS-CoV-2 › COVID 19: Diabetes and Obesity API-ICP Recommendations.